Midwest Trust Co Acquires 15,846 Shares of UnitedHealth Group Incorporated $UNH

Midwest Trust Co grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 38.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,860 shares of the healthcare conglomerate’s stock after buying an additional 15,846 shares during the period. Midwest Trust Co’s holdings in UnitedHealth Group were worth $23,633,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $25,000. Anfield Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management bought a new position in UnitedHealth Group in the 4th quarter worth $27,000. Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $29,000. 87.86% of the stock is owned by institutional investors.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 500 shares of the company’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total transaction of $205,000.00. Following the transaction, the chief executive officer owned 16,497 shares in the company, valued at $6,763,770. This represents a 2.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $401.52 on Monday. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $415.74 and a 200 day simple moving average of $352.85. The firm has a market capitalization of $360.40 billion, a price-to-earnings ratio of 25.84, a PEG ratio of 1.40 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Oppenheimer raised their target price on UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a report on Friday, July 17th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective for the company in a research report on Wednesday, April 22nd. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Barclays increased their price target on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a report on Monday, July 20th. Finally, Bank of America reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 20th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $455.92.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.